Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-024868
Filing Date
2016-09-01
Accepted
2016-09-01 16:57:01
Documents
57
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bold-10q_20160630.htm 10-Q 2090983
2 EX-31.1 bold-ex311_240.htm EX-31.1 7888
3 EX-31.2 bold-ex312_239.htm EX-31.2 7879
4 EX-32.1 bold-ex321_238.htm EX-32.1 6184
5 EX-32.2 bold-ex322_237.htm EX-32.2 6146
  Complete submission text file 0001564590-16-024868.txt   6968361

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bold-20160630.xml EX-101.INS 1697129
7 XBRL TAXONOMY EXTENSION SCHEMA bold-20160630.xsd EX-101.SCH 35822
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bold-20160630_cal.xml EX-101.CAL 37225
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bold-20160630_def.xml EX-101.DEF 130200
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bold-20160630_lab.xml EX-101.LAB 296724
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bold-20160630_pre.xml EX-101.PRE 240169
Mailing Address 101 MONTGOMERY STREET, SUITE 2650 SAN FRANCISCO CA 94104
Business Address 101 MONTGOMERY STREET, SUITE 2650 SAN FRANCISCO CA 94104 415-638-6556
Audentes Therapeutics, Inc. (Filer) CIK: 0001628738 (see all company filings)

EIN.: 461606174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37833 | Film No.: 161866309
SIC: 2836 Biological Products, (No Diagnostic Substances)